Efficacy evaluation on intestinal microbiome metabolites and metabolic disease related factors after consumption of gochujang in obesity

Not Applicable

Recruiting

• Conditions: Endocrine, nutritional and metabolic diseases

• Registration Number: KCT0006899
• Lead Sponsor: Wonkwang University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-03-21
• Last Update Posted: 2 May 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1) 23 kg/m²=BMI(Body mass index) or PBF(Percent body fat) is over 25% as male, over 30% as female.
2) Participants who have fully understand the information provided about the study voluntarily decided to participate and agree to comply with precautions

Exclusion Criteria

1) Participants who have a change of weight over 10% within 3 months prior to the screening examination
2) Participants who have an obesity surgery within 1 year
3) Patients with a clinically significant disease requiring treatment (i.e., cardiovascular system, endocrine system, immune system, respiratory system, hepatobiliary system, kidney and urinary system, neuropsychiatric system, musculoskeletal inflammation, inflammatory disease, blood and tumor disease, gastrointestinal disease, etc.)
4) Participants who have participated in other clinical trials within 3 months prior to the screening examination

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Body fat mass;changes of intestinal microbiome

Secondary Outcome Measures

Name	Time	Method
Fat free mass;Lipid metabolism index;Obesity hormone index